Drug Profile
Polyethylene glycol bovine haemoglobin conjugate
Alternative Names: PEG-bHbLatest Information Update: 28 Apr 2019
Price :
$50
*
At a glance
- Originator Beijing Kaizheng Biotech Development
- Class Haemoglobins; Polyethylene glycols
- Mechanism of Action Oxygen carriers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anaemia; Hypovolaemia
Most Recent Events
- 28 Apr 2019 No recent reports of development identified for phase-I development in Anaemia in China (Parenteral)
- 28 Apr 2019 No recent reports of development identified for phase-I development in Hypovolaemia in China (Parenteral)